Wow. It’s Friday. This week was particularly interminable, wasn’t it? This is Meghana, by the way, subbing in for Ed by way of The Readout. (Sign up here!) As we ready ourselves for the glorious weekend, here’s a roundup of some notable pharma news:
Chinese scientists have used CRISPR to correct genetic mutations in a human embryo, New Scientist reports. Though the study focused on just six human embryos, it’s showing that CRISPR seems to work better in normal embryos than it did in previous tests on abnormal embryos that couldn’t develop into children. In related news, US scientists have made some major strides in synthetically assembling a complete yeast genome, STAT’s Sharon Begley reports.